Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Silvia Stringhini¹, María-Eugenia Zaballa², Javier Perez-Saez³, Nick Pullen², Carlos de Mestral², Attilio Picazio², Francesco Pennacchio², Ania Wisniak², Aude Richard⁴, Helene Baysson⁴, Andrea Loizeau⁴, Jean-François Balavoine⁵, Didier Trono⁶, Didier Pittet⁷, Klara Posfay-Barbe⁸, Antoine Flahault⁵, François Chappuis⁹, Omar Kherad¹⁰, Nicolas Vuilleumier¹¹, Laurent Kaiser¹², Andrew S Azman¹³, Idris Guessous⁴; Specchio-COVID19 Study Group

Affiliations

¹ Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland. Electronic address: silvia.stringhini@hcuge.ch.
² Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
³ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
⁴ Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
⁵ Faculty of Medicine, University of Geneva, Switzerland.
⁶ School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
⁷ Infection Control Program and WHO Collaborating Centre on Patient Safety, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
⁸ Division of General Pediatrics, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
⁹ Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
¹⁰ Faculty of Medicine, University of Geneva, Switzerland; Division of Internal Medicine, Hôpital de la Tour, Geneva, Switzerland.
¹¹ Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
¹² Geneva Center for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
¹³ Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

PMID: 33539733
PMCID: PMC8063076
DOI: 10.1016/S1473-3099(21)00054-2

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Silvia Stringhini et al. Lancet Infect Dis. 2021 May.

. 2021 May;21(5):600-601.

doi: 10.1016/S1473-3099(21)00054-2. Epub 2021 Feb 1.

Authors

Affiliations

¹ Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland. Electronic address: silvia.stringhini@hcuge.ch.
² Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
³ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
⁴ Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
⁵ Faculty of Medicine, University of Geneva, Switzerland.
⁶ School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
⁷ Infection Control Program and WHO Collaborating Centre on Patient Safety, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
⁸ Division of General Pediatrics, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
⁹ Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
¹⁰ Faculty of Medicine, University of Geneva, Switzerland; Division of Internal Medicine, Hôpital de la Tour, Geneva, Switzerland.
¹¹ Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
¹² Geneva Center for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
¹³ Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

PMID: 33539733
PMCID: PMC8063076
DOI: 10.1016/S1473-3099(21)00054-2

No abstract available

PubMed Disclaimer

References

1. Johns Hopkins University & Medicine New cases of COVID-19 in world countries. https://coronavirus.jhu.edu/data/new-cases
1. Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313–319. - PMC - PubMed
1. Bonanad C, García-Blas S, Tarazona-Santabalbina F, et al. The effect of age on mortality in patients with Covid-19: a metanalysis with 611 583 subjects. J Am Med Dir Assoc. 2020;21:915–918. - PMC - PubMed
1. Yanez ND, Weiss NS, Romand J-A, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20 - PMC - PubMed
1. World Health Organization Regional Office for Europe Pandemic fatigue: reinvigorating the public to prevent COVID-19. https://apps.who.int/iris/bitstream/handle/10665/337574/WHO-EURO-2020-15...

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Affiliations

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Authors

Affiliations

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous